Max Multi Specaility Hospital, Noida

Name :

Max Multi Specaility Hospital, Noida

Address  :

A-364, Sector 19

Town  :

Noida

State  :

Delhi

Country  :

INDIA

Post Code:

201 301

Phone  :

91 120 254 9999

Fax  :

91 120 253 5557

Web URL  :

Max Multi Specaility Hospital Noida
Specialization
  • Anaesthesiology
  • Cardiology
  • Daibetes, Endocrinology
  • Dermatology
  • ENT
  • Gastro-enterology
  • General Surgeon
  • Internal Medicine
  • Neurologist
  • Obestetrician/Gynecologist
  • Orthopedics
  • Paediatrics
  • Physiotherapy
  • Pulmonology
Facilities

Total Number Of Beds : 50

Speciality Type :

Multi Speciality :

  • Gynaecology
  • Dental
  • Orthopedic

Other Facilities

  • Pathology
  • Physiotherapy

Advance Facility

  • Medicine Facility
  • Medical Stores

Description

Max Hospital Noida is ideally located in the centre of the city It is approximately 05 kilometres from the DND Flyover amp just 50 minutes drive from airport

Infrastructure Max Hospital Noida is centrally airconditioned and has around 50 beds with single double 4bed rooms two modular operation theatres one minor operation theatre and a 4bed ICU

Services amp Facilities The clinical services are supported with the most advanced inhouse diagnostic services It is also equipped with a stateoftheart emergency response and management system The hospital has other specialised services like Neonatal ICU NICU and an endoscopy suite and dialysis facility

OTs amp ICUs The hospital includes two major and one minor operation theatre and a 4bed ICU The operation theatre complex is located exclusively on the fourth floor with sealed modular operation theatres to minimise the surgical site infections
Liver cancer emerges as fast growing threat in country

Liver cancer is emerging as one of the fastest spreading cancers in India We get about 10 new liver cancer cases in our hospital every week and in the past two years we have seen 360 people suffering from liver cancer said Dr SK Sarin director ILBS during a twoday April 78 international symposium organised by the institute on liver cancer in the Ca... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More